Sangamo Therapeutics
SGMO
#9756
Rank
ยฃ52.57 M
Marketcap
ยฃ0.13
Share price
13.33%
Change (1 day)
-65.57%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -ยฃ83.1 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ32.87 Million. In 2024 the company made an earning of -ยฃ73.49 Million, an increase over its 2023 earnings that were of -ยฃ88.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ83.1 Million13.07%
2024 -ยฃ73.49 Million-17.27%
2023 -ยฃ88.83 Million-40.88%
2022 -ยฃ0.16 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ96.71 Million23.17%
2019 -ยฃ78.52 Million36.33%
2018 -ยฃ57.59 Million36.89%
2017 -ยฃ42.08 Million-22.32%
2016 -ยฃ54.17 Million54.86%
2015 -ยฃ34.98 Million75.62%
2014 -ยฃ19.92 Million0.13%
2013 -ยฃ19.89 Million
2011 -ยฃ26.74 Million43.66%
2010 -ยฃ18.62 Million28.52%
2009 -ยฃ14.49 Million-23.55%
2008 -ยฃ18.95 Million2.45%
2007 -ยฃ18.5 Million19.5%
2006 -ยฃ15.48 Million50.78%
2005 -ยฃ10.27 Million75%
2004 -ยฃ5.87 Million-33.25%
2003 -ยฃ8.79 Million-62.27%
2002 -ยฃ23.29 Million102.82%
2001 -ยฃ11.49 Million23.21%
2000 -ยฃ9.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.39 B-23,928.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.78 B-8,434.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.21 B-1,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ1.89 Billion 2,217.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.31 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.81 B-12,163.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.64 B-897.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.28 B-453.67%๐Ÿ‡บ๐Ÿ‡ธ USA